Jiangbin Ye

20PUBLICATIONS
90CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 03, 2026
A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC.

|Mar 13, 2026
Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer.

Xin Jin, Albert M Li, Man Zhao

|Jan 23, 2026
DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL.

Yuxuan Liu, Haowen Jiang, Jingjing Liu

|Sep 05, 2025
Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation.

Haowen Jiang, Sarah Jane Tiche, Clifford Jiajun He

|Jul 17, 2025
Exploring the oncogenic impact of heteroplasmic de novo MT-ND5 truncating mutations.

Yuanyuan Wu, Jiangbin Ye, Zhenglong Gu

|Jun 18, 2025
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5.

Man Zhao, Dalin Zhang, Haowen Jiang

Pageof 4

Frequent Collaborators

10 joint publications

Haowen Jiang

7 joint publications

Yang Li

6 joint publications

Bo He

4 joint publications

Erinn B Rankin